In his new role, Leo Landis will showcase the Society's attractions across the state and connect people both within and ...

Litigation has become another main focus of the group that’s closely connected to Leonard Leo, who helped President Donald Trump choose his three Supreme Court nominees during his first term. Hild ...

Understanding and compromise are essential today. A minor request may be perceived as controlling behavior by your partner. Ganesha advises keeping ego aside, as it could lead to unnecessary ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

Leonardo DiCaprio, long known for dating women under 25, has broken the internet dubbed “Leo's Law”, aka the under-25 rule, by continuing his relationship with Italian model Vittoria Ceretti ...

Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

The Sacklers and Purdue Pharma previously reached a $7.4 billion settlement with attorneys general from 15 states on Thursday, Jan. 23. The plan also mandates the release of more than 30 million ...

Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...

NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after ...

Leo Tanaka will be caught out on Neighbours as the soap’s murder-mystery storyline kicks off. It was announced earlier this month that the Australian soap would celebrate its 40th anniversary ...

Pharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring effort tied to shifts in its cardiovascular drug portfolio. Novartis ...